SCHEMBL24449748

SCHEMBL24449748

Bc1c(B)c(B)c2c(-c3c4c(B)c(B)c(B)c(B)c4c(-c4cccc(-c5cccc6oc7ccccc7c56)c4)c4c(B)c(B)c(B)c(B)c34)c(B)c(B)c(B)c2c1B

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.35
PLA2G2A P14555 2/20 0.33
PLA2G4A P47712 2/20 0.33
PLA2G10 O15496 1/20 0.31
MAOA P21397 2/20 0.31
CYP3A4 P08684 2/20 0.31
HPGD P15428 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
GGPS1 O95749 1/20 0.31
GABRP O00591 1/20 0.31
GABRD O14764 1/20 0.31
NPC1 O15118 1/20 0.31
CA12 O43570 1/20 0.31
TNKS O95271 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
TP53 P04637 1/20 0.31
ABCB1 P08183 1/20 0.31
PARP1 P09874 1/20 0.31
ADORA3 P0DMS8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24479433 0.92 CA1 (0.36) ALOX5PLA2G2APLA2G4APLA2G10MAOA
SCHEMBL24449659 0.89 BACE1 (0.35) ALOX5MAOACYP3A4HPGDSMN1; SMN2
SCHEMBL26591924 0.87 WEE1 (0.36) ALOX5PLA2G2APLA2G4APLA2G10
SCHEMBL25670860 0.86 ALOX5 (0.33) ALOX5PLA2G2APLA2G4AMAOACYP3A4
SCHEMBL24247344 0.86 ALOX5 (0.36) ALOX5PLA2G2APLA2G4APLA2G10MAOA
SCHEMBL25005670 0.86 PLA2G2A (0.40) ALOX5PLA2G2APLA2G4APLA2G10CYP3A4
SCHEMBL29332988 0.85 PLA2G2A (0.39) ALOX5PLA2G2APLA2G4APLA2G10MAOA
SCHEMBL24449506 0.85 BACE1 (0.34) ALOX5MAOACYP3A4HPGDSMN1; SMN2
SCHEMBL23814498 0.85 MAOA (0.34) ALOX5MAOACYP3A4HPGDSMN1; SMN2
SCHEMBL24479460 0.85 ALOX5 (0.36) ALOX5PLA2G2APLA2G4APLA2G10CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220165966-A1 ANTHRACENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2022-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220165966-A1 ANTHRACENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CRY2, CYP1A1 ALOX5 664/4885PLA2G2A 2032/4885PLA2G4A 1975/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.